Skip to main content

Table 2 Comparisons of demographic and clinical characteristics by gender in patients with epilepsy (n = 133)

From: Gender differences in prevalence and risk factors of sleep disturbances in patients with epilepsy

  Total (n = 133) Men (n = 68) Women (n = 65) p
Age (y) 30.2 ± 10.6 29.5 ± 10.7 31.0 ± 10.6 0.399
BMI (kg/m2) 22.0 ± 3.2 22.7 ± 3.4 21.2 ± 2.9 0.007
Age at seizure onset (y) 21.2 ± 11.8 21.7 ± 12.0 20.8 ± 11.7 0.644
Epilepsy duration (y) 9.0 ± 7.5 7.8 ± 7.2 10.4 ± 7.6 0.043
Nocturnal seizures (n, %) 40 (30.1) 20 (29.4) 20 (30.8) 0.865
Seizure types (n, %)     0.035
 Focal 82 (61.7) 36 (52.9) 46 (70.8)  
 General 51 (38.3) 32 (47.1) 19 (29.2)  
AEDs (n, %)     0.902
 Drug free 20 (15.2) 11 (16.4) 9 (13.8)  
 AED monotherapy 47 (35.6) 24 (35.8) 23 (35.4)  
 AED polytherapy 65 (49.2) 32 (47.8) 33 (50.8)  
Seizure frequency (n, %)     0.415
 Seizure free 29 (21.8) 17 (25.0) 12 (18.5)  
 < 1 seizure/m 40 (30.1) 22 (32.4) 18 (27.7)  
 ≥1 seizure/m 64 (48.1) 29 (42.6) 35 (53.8)  
ISI 7.6 ± 5.8 7.5 ± 5.7 7.8 ± 6.0 0.772
Moderate to severe clinical insomnia (ISI > 14) 27 (20.5) 14 (20.6) 13 (20.3) 0.969
PSQI 5.2 ± 3.0 4.9 ± 2.7 5.6 ± 3.2 0.256
Poor sleep quality (PSQI> 5) 53 (40.2) 24 (35.3) 29 (45.3) 0.241
BDI 10.5 ± 8.9 10.7 ± 9.8 10.2 ± 8.0 0.778
BAI 30.2 ± 8.5 29.8 ± 8.9 30.6 ± 8.1 0.292
  1. Data are presented as counts (%) or mean ± SD
  2. The p-values are obtained from independent-sample t-test, the chi-square test and Mann-Whitney U test
  3. BMI body mass index, AED antiepileptic drug, ISI Insomnia Severity Index, PSQI Pittsburgh Sleep Quality Index, BDI Beck Depression Inventory, BAI Beck Anxiety Inventory